Efficient control of IL-6, CRP and Ferritin in Covid-19 patients with two variants of Beta-1,3-1,6 glucans in combination, within 15 days in an open-label prospective clinical trial
Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, View ORCID ProfileSamuel JK Abraham
doi: https://doi.org/10.1101/2021.12.14.21267778
Subramanian Pushkala
1Department of Immunology, The Tamil Nadu Dr. M.G.R. Medical University, Chennai, 600032, India
Sudha Seshayyan
1Department of Immunology, The Tamil Nadu Dr. M.G.R. Medical University, Chennai, 600032, India
Ethirajan Theranirajan
2Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India
Doraisamy Sudhakar
2Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India
Kadalraja Raghavan
3Dept of Paediatric Neurology, Jesuit Antonyraj memorial Inter-disciplinary Centre for Advanced Rehabilitation and Education (JAICARE), Madurai, India
Vidyasagar Devaprasad Dedeepiya
4Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Nobunao Ikewaki
5Dept. of Medical Life Science, Kyushu University of Health and Welfare, Japan
6Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
Masaru Iwasaki
7Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
Senthilkumar Preethy
8Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Samuel JK Abraham
4Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
7Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
9Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
Data Availability
All data produced in the present work are contained in the manuscript
Posted December 16, 2021.
Efficient control of IL-6, CRP and Ferritin in Covid-19 patients with two variants of Beta-1,3-1,6 glucans in combination, within 15 days in an open-label prospective clinical trial
Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2021.12.14.21267778; doi: https://doi.org/10.1101/2021.12.14.21267778
Efficient control of IL-6, CRP and Ferritin in Covid-19 patients with two variants of Beta-1,3-1,6 glucans in combination, within 15 days in an open-label prospective clinical trial
Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2021.12.14.21267778; doi: https://doi.org/10.1101/2021.12.14.21267778
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2952)
- Dermatology (250)
- Emergency Medicine (440)
- Epidemiology (12758)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4593)
- Geriatric Medicine (420)
- Health Economics (729)
- Health Informatics (2923)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (469)
- Neurology (4366)
- Nursing (237)
- Nutrition (640)
- Oncology (2274)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6949)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (439)
- Sports Medicine (385)
- Surgery (490)
- Toxicology (60)
- Transplantation (212)
- Urology (181)